COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema

J Allergy Clin Immunol Pract. 2021 Nov;9(11):4156-4158. doi: 10.1016/j.jaip.2021.08.039. Epub 2021 Sep 14.

Authors

Lauré M Fijen¹, Marcel Levi², Danny M Cohn²

Affiliations

¹ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands. Electronic address: l.m.fijen@amsterdamumc.nl.
² Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands.

No abstract available

MeSH terms

Angioedemas, Hereditary* / diagnosis
COVID-19 Vaccines
COVID-19*
Complement C1 Inhibitor Protein
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
Complement C1 Inhibitor Protein